Member Directory

$105M Fine Against GlaxoSmithKline is Just the Cost of Doing Business

cartoon of a pharmaceutical rep holding a bottle of pills

It is seen as the cost of doing business. It may be illegal, but is also highly profitable, so why stop?

That seems to be the attitude of many pharmaceutical companies – and the latest proof of that comes in the form of a $105 million fine leveled against GlaxoSmithKline Plc.

Contact Us Today

Read More Legal News

The National Trial Lawyers White Logo for Footer
© Copyright 2022, All Rights Reserved | National Trial Lawyers
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram